Cargando…
Detection of ras gene mutations in human lung cancer: comparison of two screening assays based on the polymerase chain reaction.
We studied the prevalence of point mutations in ras oncogenes (K-ras and N-ras) in DNA from white blood cells and tumor tissue from 36 untreated patients with non-small-cell lung cancer, all of whom were smokers or ex-smokers. We observed somatic K-ras mutations in one-third of the lung carcinomas s...
Autores principales: | Husgafvel-Pursiainen, K, Ridanpää, M, Hackman, P, Anttila, S, Karjalainen, A, Onfelt, A, Børresen, A L, Vainio, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1519635/ https://www.ncbi.nlm.nih.gov/pubmed/1486847 |
Ejemplares similares
-
K-ras oncogene codon 12 point mutations in testicular cancer.
por: Ridanpää, M, et al.
Publicado: (1993) -
Interaction between smoking and asbestos in human lung adenocarcinoma: role of K-ras mutations.
por: Vainio, H, et al.
Publicado: (1993) -
Polymorphism in CYP1A1 and CYP2D6 genes: possible association with susceptibility to lung cancer.
por: Hirvonen, A, et al.
Publicado: (1993) -
Diagnostic RAS mutation analysis by polymerase chain reaction (PCR)
por: Cree, Ian A.
Publicado: (2016) -
Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients.
por: Anttila, S, et al.
Publicado: (1992)